Literature DB >> 25046220

Association between mobilization regimen and PFS after auto-SCT for multiple myeloma.

A L Garfall1, A L Dougherty1, D T Vogl1, B M Weiss1, A D Cohen1, R Mick2, U O'Doherty3, E A Stadtmauer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25046220      PMCID： PMC5503751          DOI： 10.1038/bmt.2014.153

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  6 in total

1.  Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.

Authors:  L F Porrata; M A Gertz; D J Inwards; M R Litzow; M Q Lacy; A Tefferi; D A Gastineau; A Dispenzieri; S M Ansell; I N Micallef; S M Geyer; S N Markovic
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

Review 2.  The evolving role of plerixafor in hematopoietic progenitor cell mobilization.

Authors:  Yvette C Tanhehco; Dan T Vogl; Edward A Stadtmauer; Una O'Doherty
Journal:  Transfusion       Date:  2013-01-30       Impact factor: 3.157

3.  Cyclophosphamide mobilization does not improve outcome in patients receiving stem cell transplantation for multiple myeloma.

Authors:  David Dingli; Grzegorz S Nowakowski; Angela Dispenzieri; Martha Q Lacy; Suzanne Hayman; Mark R Litzow; Dennis A Gastineau; Morie A Gertz
Journal:  Clin Lymphoma Myeloma       Date:  2006-03

4.  CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

Authors:  Abdel Kareem Azab; Judith M Runnels; Costas Pitsillides; Anne-Sophie Moreau; Feda Azab; Xavier Leleu; Xiaoying Jia; Renee Wright; Beatriz Ospina; Alicia L Carlson; Clemens Alt; Nicholas Burwick; Aldo M Roccaro; Hai T Ngo; Mena Farag; Molly R Melhem; Antonio Sacco; Nikhil C Munshi; Teru Hideshima; Barrett J Rollins; Kenneth C Anderson; Andrew L Kung; Charles P Lin; Irene M Ghobrial
Journal:  Blood       Date:  2009-01-12       Impact factor: 22.113

5.  Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.

Authors:  John F DiPersio; Edward A Stadtmauer; Auayporn Nademanee; Ivana N M Micallef; Patrick J Stiff; Jonathan L Kaufman; Richard T Maziarz; Chitra Hosing; Stefan Früehauf; Mitchell Horwitz; Dennis Cooper; Gary Bridger; Gary Calandra
Journal:  Blood       Date:  2009-04-10       Impact factor: 22.113

Review 6.  Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations.

Authors:  Sergio Giralt; Luciano Costa; Jeffrey Schriber; John Dipersio; Richard Maziarz; John McCarty; Paul Shaughnessy; Edward Snyder; William Bensinger; Edward Copelan; Chitra Hosing; Robert Negrin; Finn Bo Petersen; Damiano Rondelli; Robert Soiffer; Helen Leather; Amy Pazzalia; Steven Devine
Journal:  Biol Blood Marrow Transplant       Date:  2013-10-17       Impact factor: 5.742
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.